Figure 3

Variation of a, zero shear viscosity and b, human blood lymphocyte cell viability with AASs + HTAB (2/3, M/M) mixed surfactant concentration [C]. Systems: 1, C12MalNa2 + HTAB; 2, C12AspNa2 + HTAB and 3, C12GluNa2 + HTAB.
Variation of a, zero shear viscosity and b, human blood lymphocyte cell viability with AASs + HTAB (2/3, M/M) mixed surfactant concentration [C]. Systems: 1, C12MalNa2 + HTAB; 2, C12AspNa2 + HTAB and 3, C12GluNa2 + HTAB.